{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:00:29Z","timestamp":1790802029129,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1097\/qad.0b013e32814e6b08","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T04:04:13Z","timestamp":1180670653000},"page":"1301-1308","source":"Crossref","is-referenced-by-count":121,"title":["Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B"],"prefix":"10.1097","volume":"21","author":[{"given":"Christopher J","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Charalambous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe L","family":"Thio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond J","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindiwe","family":"Pemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin J","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison D","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"R2-9-20210130","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/jhep.2002.30319","article-title":"Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections","volume":"35","author":"Sulkowski","year":"2002","journal-title":"Hepatology"},{"key":"R3-9-20210130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S1542-3565(05)00162-X","article-title":"Hepatotoxicity nelfinavir: a meta-analysis","volume":"3","author":"Bruno","year":"2005","journal-title":"Clin Gastroent Hepatol"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1097\/00002030-200012220-00011","article-title":"Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection","volume":"14","author":"den Brinker","year":"2000","journal-title":"AIDS"},{"issue":"Suppl 2","key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1086\/381450","article-title":"Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors","volume":"38","author":"Dieterich","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R6-9-20210130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00002018-200528010-00004","article-title":"Hepatotoxicity of antiretrovirals","volume":"28","author":"Nunez","year":"2005","journal-title":"Drug Safety"},{"key":"R7-9-20210130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1086\/341084","article-title":"Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy","volume":"186","author":"Wit","year":"2002","journal-title":"J Infect Dis"},{"key":"R8-9-20210130","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/00002030-200310170-00007","article-title":"Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996\u20132001","volume":"17","author":"Law","year":"2003","journal-title":"AIDS"},{"key":"R9-9-20210130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00002030-200203290-00009","article-title":"Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy","volume":"16","author":"Dieleman","year":"2002","journal-title":"AIDS"},{"key":"R10-9-20210130","first-page":"13","article-title":"Hepatitis B and C virus infections and liver functions in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg","volume":"77","author":"Lodenyo","year":"2000","journal-title":"East Afr Med J"},{"key":"R11-9-20210130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2458-6-21","article-title":"Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania","volume":"6","author":"Matee","year":"2006","journal-title":"BMC Public Health"},{"key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","article-title":"Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine","volume":"363","author":"van Leth","year":"2004","journal-title":"Lancet"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/(SICI)1096-9071(199907)58:3<215::AID-JMV5>3.0.CO;2-K","article-title":"Prevalence and mother-to-infant transmission of hepatitis viruses B, C, and E in Southern Tanzania","volume":"58","author":"Menendez","year":"1999","journal-title":"J Med Virol"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00126334-200209010-00012","article-title":"HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi","volume":"31","author":"Sutcliffe","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jmv.20143","article-title":"HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abijan, Cote d'Ivoire: the ANRS 1236 Study","volume":"74","author":"Rouet","year":"2004","journal-title":"J Med Virol"},{"key":"R16-9-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.qai.0000219777.04927.50","article-title":"Tolerance and acceptability of an efavirenz-based regimen in 740 adults in west Africa","volume":"42","author":"Danel","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0140-6736(02)09095-5","article-title":"HIV-1\/AIDS and the control of other infectious diseases in Africa","volume":"359","author":"Corbett","year":"2002","journal-title":"Lancet"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.293.22.2719","article-title":"Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa","volume":"293","author":"Grant","year":"2005","journal-title":"JAMA"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"Dean","year":"2002","journal-title":"AIDS"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1191\/0960327102ht309oa","article-title":"The cytotoxic effects of a traditional Zulu remedy, impila","volume":"21","author":"Stewart","year":"2002","journal-title":"Hum Exp Toxicol"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1475-2891-4-19","article-title":"African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology","volume":"4","author":"Mills","year":"2005","journal-title":"Nutr J"},{"key":"R23-9-20210130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/09500340600677872","article-title":"Establishing a workplace antiretroviral therapy programme in South Africa","volume":"19","author":"Charalambous","year":"2007","journal-title":"AIDS Care"},{"key":"R24-9-20210130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1423-0410.2003.00311.x","article-title":"Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors","volume":"85","author":"Fang","year":"2003","journal-title":"Vox Sang"},{"key":"R25-9-20210130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/428093","article-title":"Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects","volume":"191","author":"Sanne","year":"2005","journal-title":"J Infect Dis"},{"key":"R26-9-20210130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.510300221","article-title":"Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy","volume":"30","author":"Liaw","year":"1999","journal-title":"Hepatology"},{"key":"R29-9-20210130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R30-9-20210130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00126334-200310010-00006","article-title":"Hospitalization rates differ by hepatitis C status in an urban HIV cohort","volume":"34","author":"Gebo","year":"2003","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200706190-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T03:02:33Z","timestamp":1618023753000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200706190-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32814e6b08","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1088091.541077","asserted-by":"object"}]},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}